But funding proposals to US agencies also tend to be more similar to previously funded projects if they are written or edited ...

Some human research will no longer be classified as a clinical trial, easing the paperwork burden, but not everyone agrees with the approach.

Hindering studies involving fetal tissue will impede the development of the alternatives intended to replace it, while ...

Gary Gibbons, M.D., is retiring as National Heart, Lung and Blood Institute (NHLBI) director, adding to the extensive churn at the top of the National Institutes of Health (NIH). The departure will ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. A deal between the federal government and groups that sued the Trump ...

The National Institutes of Health (NIH) is adding another leader to its lengthy string of departures, this time in the form of National Institute of Neurological Disorders and Stroke (NINDS) Director ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Throughout the year, researchers have been heartened by legal ...

President Donald Trump listens as Dr. Jay Bhattacharya, director of the National Institutes of Health, speaks in the Roosevelt Room of the White House on Sept. 22, 2025. Under an agreement reached ...

The U.S. National Institutes of Health (NIH) has agreed to review hundreds of medical science grant applications after they were paused under new Trump administration diversity-related restrictions.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Walter Koroshetz, director of the National Institute of Neurological Disorders and ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter.

The NIH has been transformed this year. And most of the layoffs, policy changes, and politically motivated funding cuts—notably, to infectious-disease research—have happened under Bhattacharya’s watch ...